XML 107 R4.htm IDEA: XBRL DOCUMENT v3.24.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Operating Expenses:    
Research and development $ 37,196 $ 30,324
General and administrative 13,528 13,227
Total operating expenses 50,724 43,551
Loss from operations (50,724) (43,551)
Other income (expense):    
Grant income 24,805 22,217
Other income (expense), net 158 (35)
Interest expense (27) (28)
Total other income, net 24,936 22,154
Net Loss (25,788) (21,397)
Unrealized gain (loss) on foreign currency translation 4 (1)
Total comprehensive loss $ (25,784) $ (21,398)
Net loss per share, basic (in dollars per share) $ (0.86) $ (0.91)
Net loss per share, diluted (in dollars per share) $ (0.86) $ (0.91)
Weighted-average common shares outstanding, basic (in shares) 30,029,087 23,640,199
Weighted-average common shares outstanding, diluted (in shares) 30,029,087 23,640,199